[go: up one dir, main page]

DK1372665T3 - Hormonerstatningsbehandling og administration - Google Patents

Hormonerstatningsbehandling og administration

Info

Publication number
DK1372665T3
DK1372665T3 DK02700196T DK02700196T DK1372665T3 DK 1372665 T3 DK1372665 T3 DK 1372665T3 DK 02700196 T DK02700196 T DK 02700196T DK 02700196 T DK02700196 T DK 02700196T DK 1372665 T3 DK1372665 T3 DK 1372665T3
Authority
DK
Denmark
Prior art keywords
administration
replacement therapy
hormone replacement
hormone
therapy
Prior art date
Application number
DK02700196T
Other languages
English (en)
Inventor
Hermann Kulmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1372665T3 publication Critical patent/DK1372665T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02700196T 2001-01-11 2002-01-08 Hormonerstatningsbehandling og administration DK1372665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10100911A DE10100911A1 (de) 2001-01-11 2001-01-11 Verfahren zur Hormonersatztherapie und dessen Darreichungsform
PCT/EP2002/000089 WO2002055086A2 (en) 2001-01-11 2002-01-08 Hormone replacement therapy method and its administration form

Publications (1)

Publication Number Publication Date
DK1372665T3 true DK1372665T3 (da) 2007-04-30

Family

ID=7670195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02700196T DK1372665T3 (da) 2001-01-11 2002-01-08 Hormonerstatningsbehandling og administration

Country Status (21)

Country Link
US (1) US7871994B2 (da)
EP (1) EP1372665B1 (da)
JP (1) JP2004525883A (da)
AR (1) AR033413A1 (da)
AT (1) ATE348620T1 (da)
AU (1) AU2007202118A1 (da)
BR (1) BR0206361A (da)
CA (1) CA2433656A1 (da)
CY (1) CY1106374T1 (da)
DE (2) DE10100911A1 (da)
DK (1) DK1372665T3 (da)
ES (1) ES2278896T3 (da)
IL (1) IL156655A0 (da)
MX (1) MXPA03006157A (da)
NO (1) NO20033155L (da)
NZ (1) NZ539581A (da)
PE (1) PE20020795A1 (da)
PT (1) PT1372665E (da)
UY (1) UY27117A1 (da)
WO (1) WO2002055086A2 (da)
ZA (1) ZA200306120B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538150A (ja) * 2002-08-28 2005-12-15 キャスパー,ロバート エストロゲン補充療法
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
AU2002368326A1 (en) * 2002-11-05 2004-06-07 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
DE60330888D1 (de) * 2002-11-05 2010-02-25 Bayer Schering Pharma Ag Verwendung von drospirenon zur behandlung von hypertension
JP2007506796A (ja) 2003-09-29 2007-03-22 ノボ・ノルディスク・フェムケア・アーゲー Hrt製剤
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4405590C1 (de) 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
DE4405591C1 (de) 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonsubstitution
DE19513662A1 (de) 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19539233A1 (de) 1995-10-21 1997-04-24 Klaus Dr Med Umbreit Oral einzunehmendes ovulationshemmendes Mittel

Also Published As

Publication number Publication date
US20040106586A1 (en) 2004-06-03
ATE348620T1 (de) 2007-01-15
CA2433656A1 (en) 2002-07-18
JP2004525883A (ja) 2004-08-26
PT1372665E (pt) 2007-03-30
AR033413A1 (es) 2003-12-17
ES2278896T3 (es) 2007-08-16
PE20020795A1 (es) 2002-10-03
IL156655A0 (en) 2004-01-04
BR0206361A (pt) 2004-02-17
NO20033155D0 (no) 2003-07-10
US7871994B2 (en) 2011-01-18
DE60216899D1 (de) 2007-02-01
ZA200306120B (en) 2004-09-08
DE60216899T2 (de) 2007-10-25
WO2002055086A2 (en) 2002-07-18
CY1106374T1 (el) 2011-10-12
MXPA03006157A (es) 2003-09-16
AU2007202118A1 (en) 2007-05-31
NZ539581A (en) 2007-07-27
NO20033155L (no) 2003-09-10
DE10100911A1 (de) 2002-08-01
EP1372665B1 (en) 2006-12-20
UY27117A1 (es) 2002-07-31
WO2002055086A3 (en) 2003-10-16
EP1372665A2 (en) 2004-01-02

Similar Documents

Publication Publication Date Title
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
GB0111872D0 (en) Therapeutic agents and methods
NO20034097D0 (no) Hormonerstatningsterapi
AU2002346504A8 (en) Therapeutic protein and treatments
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
DK1372665T3 (da) Hormonerstatningsbehandling og administration
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20033709L (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
GB0119025D0 (en) Compounds and their therapeutic use
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
NO20010630D0 (no) Krummet trapp og trappetrinn for krummet trapp
DK1897944T3 (da) IL-17 homologe polypeptider og terapeutisk anvendelse deraf
GB0111553D0 (en) Hormone replacement treatment therapy
GB0130736D0 (en) Compounds and their therapeutic use
GB0128512D0 (en) Compounds and their therapeutic use
SE0103855D0 (sv) Therapeutic agents
SE0103854D0 (sv) Therapeutic agents